Loading…
Asia Africa Investment and Consulting Pte Ltd (AAIC) and Ohara Pharmaceutical Company Ltd jointly invested USD 3 million into Revital Healthcare EPZ Ltd to boost its syringe production capacity from 75 million to over 400 million annually. The investment was announced on 2021-12-21.